pI: 9.0043 |
Length (AA): 714 |
MW (Da): 83120 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
175 | 267 | 2ctw (A) | 6 | 98 | 37.00 | 0 | 1 | 0.63 | -1.04 |
187 | 252 | 2ctp (A) | 8 | 72 | 46.00 | 0.0000000034 | 1 | 0.86 | -2.26 |
302 | 386 | 2yua (A) | 6 | 89 | 38.00 | 0.000000018 | 1 | 0.702648 | -1.2 |
312 | 381 | 2lo1 (A) | 5 | 71 | 55.00 | 0 | 1 | 0.886639 | -1.85 |
314 | 379 | 2ctr (A) | 8 | 72 | 48.00 | 0.00000000074 | 1 | 0.904037 | -2.48 |
315 | 379 | 2dn9 (A) | 9 | 73 | 54.00 | 0.000000000039 | 1 | 0.990636 | -2.66 |
304 | 388 | 2yua (A) | 6 | 89 | 38.00 | 0.000000014 | 1 | 0.700015 | -1.2 |
314 | 383 | 2lo1 (A) | 5 | 71 | 55.00 | 0 | 1 | 0.884065 | -1.85 |
316 | 381 | 2ctr (A) | 8 | 72 | 48.00 | 0.00000000055 | 1 | 0.901479 | -2.48 |
317 | 381 | 2dn9 (A) | 9 | 73 | 54.00 | 0.000000000028 | 1 | 0.988082 | -2.66 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, merozoite, sporozoite, early ring, late ring, late schizont, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | early trophozoite, late trophozoite. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 24 hs, early schizont. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Sporozoite. | Otto TD Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Oocyst, Female Gametocyte, Male Gametocyte. | Zanghi G Lasonder E |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_129626)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G77020 | DNAJ heat shock N-terminal domain-containing protein |
Arabidopsis thaliana | AT1G76700 | chaperone protein dnaJ 10 |
Arabidopsis thaliana | AT2G21510 | DNAJ heat shock N-terminal domain-containing protein |
Arabidopsis thaliana | AT1G21080 | DNAJ heat shock N-terminal domain-containing protein |
Arabidopsis thaliana | AT4G39150 | DNAJ heat shock N-terminal domain-containing protein |
Babesia bovis | BBOV_III003820 | dnaJ domain containing protein |
Cryptosporidium hominis | Chro.80380 | hypothetical protein |
Cryptosporidium parvum | cgd8_3270 | DNAJDNAJ protein |
Dictyostelium discoideum | DDB_G0267994 | DNAJ heat shock N-terminal domain-containing protein |
Leishmania braziliensis | LbrM.31.0670 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_310530.1 | DnaJ domain containing protein, putative |
Leishmania infantum | LinJ.31.0530 | hypothetical protein, conserved |
Leishmania major | LmjF.31.0510 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.30.0510 | hypothetical protein, conserved |
Neospora caninum | NCLIV_063240 | DnaJ homologue, related |
Oryza sativa | 4329657 | Os02g0555700 |
Oryza sativa | 4339491 | Os05g0543700 |
Oryza sativa | 4346080 | Os08g0522600 |
Oryza sativa | 4347450 | Os09g0493800 |
Oryza sativa | 9268042 | Os01g0702450 |
Plasmodium berghei | PBANKA_1238200 | DnaJ protein, putative |
Plasmodium falciparum | PF3D7_0523400 | DnaJ protein, putative |
Plasmodium falciparum | PF3D7_1149600 | DnaJ protein, putative |
Plasmodium knowlesi | PKNH_1009500 | DnaJ protein, putative |
Plasmodium vivax | PVX_080080 | hypothetical protein, conserved |
Plasmodium yoelii | PY03711 | Arabidopsis thaliana At4g39150/T22F8_50, putative |
Saccharomyces cerevisiae | YER048C | Caj1p |
Trypanosoma brucei gambiense | Tbg972.8.8650 | chaperone protein DNAj, putative |
Trypanosoma brucei | Tb927.8.8310 | chaperone protein DnaJ, putative |
Trypanosoma congolense | TcIL3000_10_13980 | chaperone protein DnaJ, putative |
Trypanosoma cruzi | TcCLB.506387.9 | chaperone DNAJ protein, putative |
Trypanosoma cruzi | TcCLB.511337.10 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508555.10 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509237.80 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_246340 | DnaJ domain-containing protein |
Theileria parva | TP02_0221 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.8310 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.8310 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.8310 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.8310 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1238200 | Plasmodium berghei | Slow | plasmo |
TGME49_246340 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.